These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 35473566)

  • 1. Selective thyroid hormone receptor beta agonist, GC-1, is capable to reduce growth of colorectal tumor in syngeneic mouse models.
    Pourvali K; Shimi G; Ghorbani A; Shakery A; Shirazi FH; Zand H
    J Recept Signal Transduct Res; 2022 Oct; 42(5):495-502. PubMed ID: 35473566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroid hormone acting via TRβ induces expression of browning genes in mouse bone marrow adipose tissue.
    Lindsey RC; Mohan S
    Endocrine; 2017 Apr; 56(1):109-120. PubMed ID: 28229360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identical gene regulation patterns of T3 and selective thyroid hormone receptor modulator GC-1.
    Yuan C; Lin JZ; Sieglaff DH; Ayers SD; Denoto-Reynolds F; Baxter JD; Webb P
    Endocrinology; 2012 Jan; 153(1):501-11. PubMed ID: 22067320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of tumor cell proliferation by thyroid hormone in a mouse model of follicular thyroid carcinoma.
    Lu C; Zhu X; Willingham MC; Cheng SY
    Oncogene; 2012 Apr; 31(16):2007-16. PubMed ID: 21909131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reactivation of the silenced thyroid hormone receptor β gene expression delays thyroid tumor progression.
    Kim WG; Zhu X; Kim DW; Zhang L; Kebebew E; Cheng SY
    Endocrinology; 2013 Jan; 154(1):25-35. PubMed ID: 23183175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The thyroid hormone receptor-beta agonist GC-1 induces cell proliferation in rat liver and pancreas.
    Columbano A; Pibiri M; Deidda M; Cossu C; Scanlan TS; Chiellini G; Muntoni S; Ledda-Columbano GM
    Endocrinology; 2006 Jul; 147(7):3211-8. PubMed ID: 16574785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRβ Agonism Induces Tumor Suppression and Enhances Drug Efficacy in Anaplastic Thyroid Cancer in Female Mice.
    Gillis NE; Cozzens LM; Wilson ER; Smith NM; Tomczak JA; Bolf EL; Carr FE
    Endocrinology; 2023 Aug; 164(10):. PubMed ID: 37702560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor suppressor action of liganded thyroid hormone receptor beta by direct repression of beta-catenin gene expression.
    Guigon CJ; Kim DW; Zhu X; Zhao L; Cheng SY
    Endocrinology; 2010 Nov; 151(11):5528-36. PubMed ID: 20844001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of tumorigenesis by the thyroid hormone receptor β in xenograft models.
    Kim WG; Zhao L; Kim DW; Willingham MC; Cheng SY
    Thyroid; 2014 Feb; 24(2):260-9. PubMed ID: 23731250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroid Hormone Receptor β Agonist Induces β-Catenin-Dependent Hepatocyte Proliferation in Mice: Implications in Hepatic Regeneration.
    Alvarado TF; Puliga E; Preziosi M; Poddar M; Singh S; Columbano A; Nejak-Bowen K; Monga SP
    Gene Expr; 2016; 17(1):19-34. PubMed ID: 27226410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The thyroid receptor β modulator GC-1 reduces atherosclerosis in ApoE deficient mice.
    Kannisto K; Rehnmark S; Slätis K; Webb P; Larsson L; Gåfvels M; Eggertsen G; Parini P
    Atherosclerosis; 2014 Dec; 237(2):544-54. PubMed ID: 25463087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic signaling of KRAS and thyroid hormone receptor β mutants promotes undifferentiated thyroid cancer through MYC up-regulation.
    Zhu X; Zhao L; Park JW; Willingham MC; Cheng SY
    Neoplasia; 2014 Sep; 16(9):757-69. PubMed ID: 25246276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the RhoB signaling pathway by thyroid hormone receptor β in thyroid cancer cells.
    Ichijo S; Furuya F; Shimura H; Hayashi Y; Takahashi K; Ohta K; Kobayashi T; Kitamura K
    PLoS One; 2014; 9(12):e116252. PubMed ID: 25548921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting thyroid hormone receptor beta in triple-negative breast cancer.
    Gu G; Gelsomino L; Covington KR; Beyer AR; Wang J; Rechoum Y; Huffman K; Carstens R; Andò S; Fuqua SA
    Breast Cancer Res Treat; 2015 Apr; 150(3):535-45. PubMed ID: 25820519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common tumor-suppressive signaling of thyroid hormone receptor beta in breast and thyroid cancer cells.
    Bolf EL; Gillis NE; Davidson CD; Cozzens LM; Kogut S; Tomczak JA; Frietze S; Carr FE
    Mol Carcinog; 2021 Dec; 60(12):874-885. PubMed ID: 34534367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A rapid cytoplasmic mechanism for PI3 kinase regulation by the nuclear thyroid hormone receptor, TRβ, and genetic evidence for its role in the maturation of mouse hippocampal synapses in vivo.
    Martin NP; Marron Fernandez de Velasco E; Mizuno F; Scappini EL; Gloss B; Erxleben C; Williams JG; Stapleton HM; Gentile S; Armstrong DL
    Endocrinology; 2014 Sep; 155(9):3713-24. PubMed ID: 24932806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of TSH in the spontaneous development of asymmetrical thyroid carcinoma in mice with a targeted mutation in a single allele of the thyroid hormone-β receptor.
    Zhao L; Zhu X; Won Park J; Fozzatti L; Willingham M; Cheng SY
    Endocrinology; 2012 Oct; 153(10):5090-100. PubMed ID: 22919057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural basis of GC-1 selectivity for thyroid hormone receptor isoforms.
    Bleicher L; Aparicio R; Nunes FM; Martinez L; Gomes Dias SM; Figueira AC; Santos MA; Venturelli WH; da Silva R; Donate PM; Neves FA; Simeoni LA; Baxter JD; Webb P; Skaf MS; Polikarpov I
    BMC Struct Biol; 2008 Jan; 8():8. PubMed ID: 18237438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained zero-order delivery of GC-1 from a nanochannel membrane device alleviates metabolic syndrome.
    Filgueira CS; Nicolov E; Hood RL; Ballerini A; Garcia-Huidobro J; Lin JZ; Fraga D; Webb P; Sabek OM; Gaber AO; Phillips KJ; Grattoni A
    Int J Obes (Lond); 2016 Nov; 40(11):1776-1783. PubMed ID: 27460601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The thyroid hormone receptor beta-specific agonist GC-1 selectively affects the bone development of hypothyroid rats.
    Freitas FR; Capelo LP; O'Shea PJ; Jorgetti V; Moriscot AS; Scanlan TS; Williams GR; Zorn TM; Gouveia CH
    J Bone Miner Res; 2005 Feb; 20(2):294-304. PubMed ID: 15647824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.